Categories USA News

Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company.

More From Author

You May Also Like

Meet Aardvark, OpenAI’s security agent for code analysis and patching

OpenAI has introduced Aardvark, a GPT-5-powered autonomous security researcher agent now available in private beta.…

Why IT leaders should pay attention to Canva’s ‘imagination era’ strategy

The rise of AI marks a critical shift away from decades defined by information-chasing and…

Meta researchers open the LLM black box to repair flawed AI reasoning

Researchers at Meta FAIR and the University of Edinburgh have developed a new technique that…